{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:09:18Z","timestamp":1791234558709,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.06.002","type":"journal-article","created":{"date-parts":[[2003,10,30]],"date-time":"2003-10-30T10:51:23Z","timestamp":1067511083000},"page":"1320-1326","source":"Crossref","is-referenced-by-count":77,"title":["Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis"],"prefix":"10.1016","volume":"22","author":[{"given":"R.X.","family":"Armijos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calvopina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cevallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.06.002_BIB1","unstructured":"World Health Organization. Control of the Leishmaniasis. Technical Report Series #793. Geneva: WHO; 1990."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB2","unstructured":"Pan American Health Organization. Leishmaniasis in the Americas. Epidemiol Bull 1994;15:8\u201313."},{"issue":"3","key":"10.1016\/j.vaccine.2003.06.002_BIB3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony","volume":"34","author":"Chulay","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/clinids\/10.3.560","article-title":"Chemotherapy for leishmaniasis: biochemical mechanisms","volume":"10","author":"Berman","year":"1988","journal-title":"Rev. Inf. Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2003.06.002_BIB6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0035-9203(89)90327-1","article-title":"Concentration of Pentostam in human breast milk","volume":"83","author":"Berman","year":"1989","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.vaccine.2003.06.002_BIB7","first-page":"144","article-title":"Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment","volume":"28","author":"Weigel","year":"1994","journal-title":"Bull. Pan. Am. Health Organ."},{"issue":"6","key":"10.1016\/j.vaccine.2003.06.002_BIB8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1590\/S1020-49892001001200005","article-title":"The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador","volume":"10","author":"Weigel","year":"2001","journal-title":"Pan. Am. J. Pub. Health"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB9","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/515265","article-title":"Field trial of a vaccine against New World cutaneous leishmaniasis in at-risk child population: safety, immunogenecity, and efficacy during the first 12 months of follow-up","volume":"177","author":"Armijos","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2003.06.002_BIB10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Moddaber","year":"1995","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0035-9203(86)90296-8","article-title":"Further trials of a vaccine against American cutaneous leishmaniasis","volume":"80","author":"Mayrink","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trial of a vaccine against New World cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00034983.1985.11811917","article-title":"An experimental vaccine against American dermal leishmaniasis: experience in the State of Spirito Santo, Brazil","volume":"79","author":"Mayrink","year":"1985","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB14","unstructured":"UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases. Tropical disease research: progress 1995\u20131996. In: Thirteenth Programme Report of the UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases; 1997."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB15","unstructured":"Armijos RX. Phase I and II Studies of the Safety and Immunogenecity of the Leishvaccin\u00ae (Biobras Pharmaceutical Company) in a non-endemic Ecuadorian population: final technical report to the Special Programme for Research and Training in Tropical Diseases (TDR)\/UNDP\/WB\/WHO) #TDR950174; 1998."},{"issue":"suppl.I","key":"10.1016\/j.vaccine.2003.06.002_BIB16","first-page":"46","article-title":"Characterizationof the cell-mediated immune response induced by a vaccine against American tegumentary leishmaniasis in humans","volume":"88","author":"Mendonca","year":"1993","journal-title":"Mem. Inst. Oswaldo. Cruz."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0074-02761998000200014","article-title":"Phase I study of an inactivated vaccine against American cutaneous tegumentary in normal volunteers in Brazil","volume":"93","author":"Marzochi","year":"1998","journal-title":"Men Inst. Oswaldo. Cruz."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0035-9203(00)90239-6","article-title":"Safety and immunogenicity of a killed Leishmania (L) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial","volume":"94","author":"Velez","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of stability and immunogenecity of autoclaved and nonautoclaved preparation of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"De Luca","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0001-706X(01)00181-4","article-title":"A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American cutaneous leishmaniasis","volume":"80","author":"De Luca","year":"2001","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.vaccine.2003.06.002_BIB21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-3156.1997.d01-236.x","article-title":"Epidemiology of cutaneous leishmaniasis in an endemic area of subtropical Ecuador","volume":"2","author":"Armijos","year":"1997","journal-title":"Trop. Med. Int. Health"},{"issue":"5","key":"10.1016\/j.vaccine.2003.06.002_BIB22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4269\/ajtmh.1990.42.424","article-title":"Human cutaneous leishmaniasis in Ecuador: characterization of parasites by isoenzyme electrophoresis","volume":"45","author":"Armijos","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1051\/parasite\/1995023301","article-title":"Analyse chimiotaxonomique de vingt-deux souches de Leishmania isolees au Nord-Ouest de l\u2019Equateur","volume":"2","author":"Armijos","year":"1995","journal-title":"Parasite"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4269\/ajtmh.1995.53.195","article-title":"Caracterization of human T lymphocyte\u2014mediated immune response by a vaccine against American tegumentary leishmaniasis","volume":"53","author":"Mendonca","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomized, double-blind controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB26","first-page":"29","article-title":"Leishmaniasis in Brazil. XII. Observation on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L.m. amazonensis, Leishmania braziliensis braziliensis, L.b. guyanensis and L.b. panamensis","volume":"80","author":"Laison","year":"1977","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0140-6736(90)91945-7","article-title":"Recurrent lesions in humans Leishmania braziliensis infection-reactivation or reinfection?","volume":"336","author":"Saravia","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182098002789","article-title":"The gp-63 gene locus a target for genetic characterization of Leishmania belonging to subgenus","volume":"117","author":"Victoir","year":"1998","journal-title":"Viannia. Parasitol."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0031182000007125","article-title":"Gp63 gene polymorphysm and population structure of Leishmania donovani complex: influence of the host selection pressure?","volume":"122","author":"Guerbouj","year":"2001","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2003.06.002_BIB30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1471-4922(01)01895-5","article-title":"Is lipophosphoglycan a virulent factor? A surprising diversity between Leishmania species","volume":"17","author":"Turco","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.vaccine.2003.06.002_BIB31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(98)00057-6","article-title":"Identification of Mexican Leishmania species by analysis of PCR amplified DNA","volume":"71","author":"Hernandez-Montes","year":"1998","journal-title":"Acta Trop."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:17:34Z","timestamp":1585221454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":31,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007060"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.06.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}